D1000 Varejo Farma Participacoes SA

D1000 Varejo Farma Participacoes SA

6.65
BRL
+0.09
(+1.37%)
0.47EPS
15.09P/E
361.30MMarket Cap
Nov 11Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
22.59
42.93
41.87
19.85
22.56
29.31
34.56
42.7
52.7
54.52
Basic EPS, GAAP
-1.43
0.1
-0.28
- -
0.04
0.22
0.42
0.51
0.45
0.47
Free Cash Flow per Basic Share
-2.45
-1.87
1.54
-0.53
0.76
1.23
1.74
1.62
1.44
2.48
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
5.08
9.71
9.21
16.52
16.56
16.79
17.21
17.72
18.17
18.2
Tangible Book Value per Share
-8.27
-3.43
-3.11
4.37
4.5
4.85
5.34
5.74
6.19
6.21
Basic Weighted Avg Shares
51
27
27
51
51
51
51
51
51
51
Sales/Revenue/Turnover
1,143
1,161
1,132
1,004
1,141
1,483
1,749
2,161
2,667
2,759
Operating Margin (%)
-3.41
0.82
1.16
0.66
-0.1
2.4
2.93
2.93
3.15
3.62
Depreciation Expense
23
22
71
77
94
97
105
118
135
139
Net Income, GAAP
-72
3
-7
- -
2
11
21
26
23
24
Effective Tax Rate (%)
- -
- -
279.33
- -
- -
11.13
18.69
9.16
- -
- -
Profit Margin (%)
-6.33
0.23
-0.66
0.01
0.17
0.77
1.22
1.2
0.85
0.87
Working Capital
-242
-79
-86
165
37
68
64
74
47
33
LT Debt
19
87
205
215
202
214
209
324
370
386
Total Equity
257
492
466
836
838
849
871
897
919
921
Return on Invested Capital (%)
- -
- -
4.82
- -
- -
2.75
3.62
4.62
- -
- -
Return on Capital (%)
- -
- -
-10.47
- -
- -
3.29
3.93
4.67
- -
- -
Return on Common Equity (%)
- -
0.72
-1.56
0.02
0.24
1.35
2.48
2.93
2.49
2.64

Capital Structure

BRL

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
112
139
149
LT Borrowings
3
50
48
LT Finance Leases
321
321
338
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
253
349
361

Working Capital

BRL

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
628
620
618
Cash, Cash Equivalents & STI
14
46
23
Accounts Receivable, Net
275
240
236
Inventories
269
278
293
Total Current Liabilities
590
573
585
Payables & Accruals
- -
- -
- -
ST Debt
112
139
149
Deferred Revenue
- -
- -
- -

Growth Rates

BRL

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
1.92%
2.52%
Free Cash Flow
- -
-31.89%
-11.19%
Net Income, GAAP
- -
415.83%
-12.73%
Sales/Revenue/Turnover
- -
21.69%
23.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
482
513
544
621
2,161
2025
568
677
731
690
2,667
2026
660
- -
- -
- -
- -

Quarterly Earnings Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.22
0.2
0.07
0.51
2025
- -
0.11
0.15
0.19
0.45
2026
0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Sammy Birmarcker
Sector
Distribution services
Industry
Medical distributors
Address
Rio de Janeiro Brazil
IPO Date
Aug 10, 2020
Business
D1000 Varejo Farma Participacoes SA is a Brazil-based retail holding company engaged in the commercialization and distribution of pharmaceutical, healthcare, personal care, and beauty products. The company operates through a multi-banner network of retail pharmacies, digital e-commerce platforms, and direct-to-consumer fulfillment channels. Its core product and service portfolio encompasses prescription and over-the-counter medications; generic, branded, and reference pharmaceuticals; dermocosmetics and clinical skincare treatments; personal hygiene and body care supplies, including hair care, oral health items, and deodorants; vitamins, nutritional supplements, and wellness goods; infant care, baby formula, and maternity essentials; home healthcare monitoring devices and first-aid supplies; as well as in-store clinical pharmaceutical services, such as blood glucose measurement, blood pressure monitoring, injectable medication administration, rapid diagnostic tests, and pharmaceutical consultations. D1000 Varejo Farma Participacoes SA serves the Brazilian consumer market through four specialized retail banners: Drogasmil, a traditional retail pharmacy brand primarily serving the State of Rio de Janeiro; Farmalife, a premium drugstore chain focused on beauty, wellness, and dermocosmetics located in high-traffic shopping centers; Drogarias Tamoio, a convenience and value-oriented pharmacy chain operating across suburban and metropolitan Rio de Janeiro; and Drogaria Rosario, which maintains an extensive presence throughout Brazil's Central-West region, including the Federal District, Goias, Mato Grosso, and Tocantins. Founded in 2013 and headquartered in Rio de Janeiro, Brazil, the company operates as the retail subsidiary of Profarma Distribuidora de Produtos Farmaceuticos SA. In recent developments, D1000 Varejo Farma Participacoes SA has executed a strategic store portfolio optimization program, modernizing existing retail outlets, refining store layout standards, and selectively rationalizing non-performing locations to improve profitability. The company has also expanded its omnichannel retail infrastructure by enhancing proprietary mobile applications, integrating on-demand delivery partnerships with quick-commerce platforms, broadening its private-label product lines in hygiene and wellness, and deepening logistics and procurement synergies with its parent corporation to optimize working capital and supply chain efficiency.